(Q33156368)

22 July 2017

1 reference

title

Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA. (English)

1 reference

22 July 2017

3

Grace M Lee

1 reference

22 July 2017

Courtney A Gidengil

1

1 reference

22 July 2017

Thomas J Sandora

series ordinal

2

1 reference

22 July 2017

publication date

1 July 2008

1 reference

Expert Review of Vaccines

22 July 2017

published in

1 reference

22 July 2017

volume

7

1 reference

22 July 2017

issue

5

1 reference

22 July 2017

page(s)

621-634

1 reference

A commentary on the pathogenesis of pertussis

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Epidemiological features of pertussis in the United States, 1980-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

The recurrence of whooping cough: possible implications for assessment of vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Epidemiological, clinical, and laboratory aspects of pertussis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Trends in pertussis among infants in the United States, 1980-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

A "new age" in pertussis prevention new opportunities through adult vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Prevalence and incidence of adult pertussis in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Efficacy of an acellular pertussis vaccine among adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

A search for Bordetella pertussis infection in university students

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

The science and fiction of the "resurgence" of pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Duration of immunity against pertussis after natural infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Pertussis: increasing disease as a consequence of reducing transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Temporal trends in circulating Bordetella pertussis strains in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Epidemiology of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Factors influencing the spread of pertussis in households.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Morbidity of pertussis in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Transmission of Bordetella pertussis to young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Pertussis sources of infection and routes of transmission in the vaccination era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Severe and unrecognised: pertussis in UK infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Infant pertussis: who was the source?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Societal costs and morbidity of pertussis in adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Pertussis of adults and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Impact of nasopharyngeal swab types on detection of Bordetella pertussis by PCR and culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Microbiological and serological diagnosis of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Diagnosis of community-acquired pertussis infection: comparison of both culture and fluorescent-antibody assays with PCR detection using electrophoresis or dot blot hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Issues associated with and recommendations for using PCR to detect outbreaks of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Azithromycin for the treatment of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Short-term treatment of pertussis with azithromycin in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Recent developments in pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Cost effectiveness of pertussis vaccination in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Adolescent and adult pertussis vaccination: computer simulations of five new strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

High incidence of pertussis among Hajj pilgrims.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Role of maternal pertussis antibodies in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

New combined tetanus-diptheria-acellular pertussis vaccines for adults: primary care physician attitudes and preferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Knowledge, Attitude, and Practices With Regard to Adult Pertussis Vaccine Booster in Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Prospective Multinational Study of Pertussis Infection in Hospitalized Infants and Their Household Contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

The seroepidemiology of Bordetella pertussis infection in Western Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

An acellular pertussis vaccine in healthy adults: safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.621

21 January 2018

Identifiers

DOI

10.1586/14760584.7.5.621

1 reference

22 July 2017

1 reference